SG47100A1 - Use of insulin sensitisers for treating renal diseases - Google Patents

Use of insulin sensitisers for treating renal diseases

Info

Publication number
SG47100A1
SG47100A1 SG1996007235A SG1996007235A SG47100A1 SG 47100 A1 SG47100 A1 SG 47100A1 SG 1996007235 A SG1996007235 A SG 1996007235A SG 1996007235 A SG1996007235 A SG 1996007235A SG 47100 A1 SG47100 A1 SG 47100A1
Authority
SG
Singapore
Prior art keywords
renal diseases
treating renal
insulin sensitisers
sensitisers
insulin
Prior art date
Application number
SG1996007235A
Inventor
Robin Edwin Buckingham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9402624A external-priority patent/GB9402624D0/en
Priority claimed from GB9410214A external-priority patent/GB9410214D0/en
Priority claimed from GBGB9426019.7A external-priority patent/GB9426019D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SG47100A1 publication Critical patent/SG47100A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
SG1996007235A 1994-02-10 1995-02-07 Use of insulin sensitisers for treating renal diseases SG47100A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9402624A GB9402624D0 (en) 1994-02-10 1994-02-10 Novel method
GB9410214A GB9410214D0 (en) 1994-05-21 1994-05-21 Novel method
GBGB9426019.7A GB9426019D0 (en) 1994-12-22 1994-12-22 Novel method

Publications (1)

Publication Number Publication Date
SG47100A1 true SG47100A1 (en) 1998-03-20

Family

ID=27267046

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007235A SG47100A1 (en) 1994-02-10 1995-02-07 Use of insulin sensitisers for treating renal diseases

Country Status (11)

Country Link
EP (1) EP0777469A1 (en)
JP (1) JPH09512249A (en)
CN (2) CN1083715C (en)
AP (1) AP553A (en)
AU (1) AU700826B2 (en)
CA (1) CA2182986A1 (en)
IL (1) IL112590A (en)
MX (1) MX9603338A (en)
SG (1) SG47100A1 (en)
TW (1) TW475896B (en)
WO (1) WO1995021608A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5985884A (en) * 1996-07-01 1999-11-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6011036A (en) * 1997-04-15 2000-01-04 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
WO2000064892A2 (en) 1999-04-23 2000-11-02 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
HUP0202438A2 (en) * 1999-08-17 2002-12-28 Smithkline Beecham Plc. Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
US20040115626A1 (en) * 2000-05-25 2004-06-17 Masahide Goto Human pgc-1 promoter
GB0019223D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
WO2006096398A2 (en) * 2005-03-03 2006-09-14 Smithkline Beecham Corporation Medicaments
US20100099640A1 (en) 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
FR2680512B1 (en) * 1991-08-20 1995-01-20 Adir NOVEL 2,4-THIAZOLIDINEDIONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JPH05310719A (en) * 1992-04-28 1993-11-22 Terumo Corp Thiazolidine-2,4-dione derivative

Also Published As

Publication number Publication date
EP0777469A1 (en) 1997-06-11
TW475896B (en) 2002-02-11
CN1318372A (en) 2001-10-24
AP553A (en) 1996-11-06
IL112590A0 (en) 1995-06-29
WO1995021608A1 (en) 1995-08-17
IL112590A (en) 2002-08-14
CN1145027A (en) 1997-03-12
CN1083715C (en) 2002-05-01
AU700826B2 (en) 1999-01-14
CA2182986A1 (en) 1995-08-17
AU1578395A (en) 1995-08-29
AP9500717A0 (en) 1995-04-30
JPH09512249A (en) 1997-12-09
MX9603338A (en) 1997-03-29

Similar Documents

Publication Publication Date Title
SG47100A1 (en) Use of insulin sensitisers for treating renal diseases
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
GB9421709D0 (en) Therapeutic compounds
SG63679A1 (en) Disposable diaper
TW466944U (en) Disposable diaper
TW341116U (en) Disposable diaper
EP0724870A3 (en) Disposable diaper
TW380421U (en) Disposable diaper
HRP950382B1 (en) Therapeutic compounds
TW538744U (en) Disposable diaper
TW294963U (en) Disposable diaper
TW365809U (en) Disposable diaper
HK1010681A1 (en) Disposable diaper
NZ283957A (en) Benzamide-containing medicaments suitable for treating neurodegenerative diseases
AP9200428A0 (en) Compounds for treating leukotriene-related diseases
IL98387A0 (en) Pyridyl-benzoic acid derivatives for treating leukotriene-related diseases
TW311446U (en) Disposable diaper
HUT74382A (en) Use of insulin sensitisers for treating renal diseases
AU697136B2 (en) Agents for treating metabolic bone diseases
IL98412A0 (en) Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases
EP0774260A4 (en) Remedy for corneal diseases
EP0715840A3 (en) Disposable diaper
TW325679U (en) Disposable diaper
ZA987960B (en) Methods for treating ocular diseases
PL309497A1 (en) Agent for treating chronic skin diseases